Giuseppina La Sala

Also affiliated with AstraZeneca (Finland), AstraZeneca (Sweden), Institut des Maladies Métaboliques et Cardiovasculaires

ChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders”.

Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders

Chem(2020)10.1016/j.chempr.2020.06.017

N/A

0DataRank · unranked

63 citations

Marco Borgogno, Roberto Narducci, Giuseppina La Sala, José Antonio Ortega, Maria Summa +6 more

Structure-based Design of CDC42 Effector Interaction Inhibitors For the Treatment of Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.14.464305

N/A

0DataRank · unranked

1 citations

José Antonio Ortega, Linh M. Vuong, Isabella Maria Acquistapace, Stephanie J. Hachey, Jessica L. Flesher +17 more

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

Cell Reports(2022)10.1016/j.celrep.2022.110641

N/A

0DataRank · unranked

19 citations

José Antonio Ortega, Linh M. Vuong, Isabella Maria Acquistapace, Stephanie J. Hachey, Jessica L. Flesher +17 more